This is the authors' abstract. We don't add key points for this paper.
TANs recruit macrophages and Treg cells to HCCs to promote their growth, progression, and resistance to sorafenib.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: